AI assistant
Gubra A/S — Director's Dealing 2026
Jun 4, 2026
6302_rns_2026-06-04_b7ef6b87-d13c-4ad3-ba1d-adca08bfd5e9.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Regulatory press release
04 June 2026 10:19:00 CEST
gubra
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
Pursuant to the Market Abuse Regulation article 19, Gubra A/S, CVR no. 30514041 (the "Company") hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in the Company and persons closely associated with them in the Company's shares and other financial instruments linked thereto.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |
|---|---|---|
| a) | Name | Markus Rohrwild |
| 2. | Reason for the notification | |
| a) | Position/status | Chief Executive Officer |
| b) | Initial notification/ Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Gubra A/S |
| b) | LEI | 254900T17RRFZONO6W53 |
| 4.1 | Details of the transaction(s): | |
| a) | Description of the financial instrument, type of instrument | Warrants related to the shares of Gubra A/S |
| Identification code | Shares (ISIN DK0062266474) | |
| b) | Nature of the transaction | Warrants granted free of charge in connection with the Company's incentive programme. |
Gubra
Hørsholm Kongevej 11B
2970 Hørsholm
Regulatory press release
04 June 2026 10:19:00 CEST
gubra
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
|---|---|---|---|
| DKK 0 | 31,147 | ||
| d) | Aggregated information | ||
| — Aggregated volume | |||
| — Price | Average price per share: DKK 0 | ||
| Total number of warrants: 31,147 | |||
| Total price: DKK 0 | |||
| e) | Date of the transaction | 2 June 2026 | |
| f) | Place of the transaction | Outside a trading venue |
Contacts at Gubra
Media: Marianne Thomas ([email protected], +45 2483 2663)
Investors: Kristian Borbos ([email protected], +45 3080 8035) and Adam Lange ([email protected], +45 +45 6646 1589)
About Gubra
Gubra, founded in 2008 in Denmark and listed on NASDAQ Copenhagen, is a disease-agnostic techbio company specialized in peptide-based drug discovery and preclinical contract research services. Gubra's activities are focused on the early stages of drug development and are organized in three main business units – Biotech, CRO, and Ventures. The business areas create a unique entity capable of generating a steady cash flow from the CRO business while investing in high-impact biotech R&D projects with significant value inflection potential through partnerships. Gubra has around 300 employees and had revenue of DKK 2.6 billion (around $400 million) in 2025. See www.gubra.dk for more information.
Gubra
Hørsholm Kongevej 11B
2970 Hørsholm